OClawVPS.com
IndieBio
Edit

IndieBio

https://indiebio.co
Last activity: 12.01.2026
Active
A 4 month biotech accelerator program that provides $250k funding, lab space and mentorship.
Likes
9.75K
Portfolio
10
Persons
1
Mentions
99
Location: United States, California, San Francisco
Employees: 1-10
Investment Type: Venture Capital; Accelerator

Portfolio 10

DateNameWebsiteTotal RaisedLocation
01.03.2023FluoSphera...fluosphera.com$3.71MSwitzerlan...
01.02.2023Alunaalunacare.com$15.3MUnited Sta...
21.09.2022west~bourn...westbourne.com$525KUnited Sta...
21.09.2022Gozen Biow...gozen-bioworks.com$525KTurkey, Ma...
07.09.2022Puna Biopuna.bio$3.7MArgentina,...
14.03.2022Stämm Biot...stamm.bio$20MUnited Sta...
16.02.2021OncoPrecis...oncoprecision.bio$6.85MArgentina,...
31.07.2020Geltorgeltor.com$109.5MUnited Sta...
29.07.2020Joywell Fo...joywellfoods.com$31.9MUnited Sta...
17.06.2016Metabolomi...metabolomicdiagnostics.com$4.36MIreland, C...

Persons 1

DateFirst NameLast NameTitleLinkedIn
-ParikshitSharmaPartnerlinkedin.c...

Mentions in press and media 99

DateTitleDescription
13.01.2026FluoSphera Secures €1.23M to Revolutionize Drug Discovery with Human-Relevant PlatformFluoSphera, a Swiss biotech firm, secured €1.23 million. This vital funding propels its advanced drug discovery platform. The patented multi-tissue system offers animal-free, human-relevant testing. It predicts drug effects with high accura...
12.01.2026Female-led Swiss BioTech FluoSphera secures €1.23 million to advance animal-free, human-relevant drug discoveryGeneva-based BioTech startup FluoSphera today announced that it has raised €1.23 million (CHF 1.15 million) in funding to make drug discovery faster, safer, and more human-relevant with its patented multi-tissue platform. The round was led ...
12.01.2026FluoSphera secures €1.23M to expand human-based preclinical platformFluoSphera, a Swiss biotech startup focused on drug safety and efficacy testing, has raised €1.23 million (CHF1.15 million) in funding. The round was led by Soulmates Ventures and a Swiss business angel, with participation from IndieBio New...
02.11.2025Helex: $3.5 Million Seed Funding Closed To Advance Non-Viral Gene Therapies for Genetic Kidney DiseasesHelex, a therapeutics company pioneering targeted non-viral gene therapies for kidney diseases, has raised an oversubscribed $3.5 million Seed round led by pi Ventures, with participation from Bluehill Capital, SOSV, and a global syndicate ...
30.10.2025iOrganBio Raises $2M in FundingiOrganBio, a Chapel Hill, NC-based human cell production company, raised $2m in funding. The round was led by First Star Ventures along with institutional investors IndieBio, Cape Fear BioCapital, 2ndF, Terasaki Institute, and Alix Ventures...
30.10.2025iOrganBio: $2 Million Raised For Developing AI-Based Cell Manufacturing SolutionsiOrganBio, a biotechnology startup developing AI-based cell manufacturing solutions, has emerged from stealth with $2 million in seed funding to launch CellForge, the first artificial intelligence-powered platform for scalable and reproduci...
17.10.2025Sunday Supper Launches Equity Crowdfunding on Wefunder With High Early InterestPlant-based food company Sunday Supper has launched an equity crowdfunding campaign through Wefunder as it continues to grow its footprint in the frozen food sector. The brand, which focuses on vegan Italian comfort food has already secured...
10.10.2025Asterix Foods Raises $4.2M to Disrupt Protein Production with Affordable Plant Cell TechnologyAsterix Foods, a food-tech startup based in Tel Aviv, has raised $4.2 million in a Seed funding round led by CPT Capital, with additional backing from ReGen Ventures, SOSV, Grok Ventures, and the Israeli Innovation Authority. The company, w...
28.04.2025GRIDX: Interview With Co-Founder Matias Peire About The Life Sciences VC FirmGRIDX is the leading venture capital fund for life sciences companies in Latin America. Pulse 2.0 interviewed GRIDX founder and CEO Matias Peire to learn more about the firm. Matias Peire’s Background What is Matias Peire’s background? Peir...
12.04.2025India's Life Sciences Boom: A Double-Edged SwordIndia's life sciences sector is on a rollercoaster ride. Over the past five years, it has attracted a staggering USD 1.9 billion in investments. This surge, however, comes with a caveat. The investment landscape is shifting, and the future ...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In